Total Payments
$16,110
2024 Payments
$481.12
Companies
60
Transactions
869
Medicare Patients
1,495
Medicare Billing
$106,519
Payment Breakdown by Category
Food & Beverage$12,653 (78.5%)
Other$3,360 (20.9%)
Education$96.37 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,653 | 861 | 78.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,360 | 1 | 20.9% |
| Education | $96.37 | 7 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,973 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,074 | 80 | $0 (2024) |
| Novo Nordisk Inc | $1,401 | 100 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,004 | 82 | $0 (2024) |
| PFIZER INC. | $906.92 | 133 | $0 (2024) |
| GlaxoSmithKline, LLC. | $794.22 | 53 | $0 (2023) |
| Lilly USA, LLC | $720.30 | 54 | $0 (2024) |
| Amarin Pharma Inc. | $595.70 | 48 | $0 (2021) |
| Amgen Inc. | $367.37 | 21 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $365.95 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $481.12 | 22 | AstraZeneca Pharmaceuticals LP ($139.35) |
| 2023 | $1,038 | 50 | AbbVie Inc. ($232.34) |
| 2022 | $4,508 | 63 | ABBVIE INC. ($3,589) |
| 2021 | $1,259 | 80 | Boehringer Ingelheim Pharmaceuticals, Inc. ($170.88) |
| 2020 | $1,790 | 121 | Novo Nordisk Inc ($257.20) |
| 2019 | $2,282 | 175 | AstraZeneca Pharmaceuticals LP ($374.16) |
| 2018 | $2,241 | 179 | AstraZeneca Pharmaceuticals LP ($422.57) |
| 2017 | $2,512 | 179 | AstraZeneca Pharmaceuticals LP ($526.29) |
All Payment Transactions
869 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.20 | General |
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.30 | General |
| 09/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $24.47 | General |
| 07/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Diabetes | ||||||
| 05/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 04/03/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Obesity | ||||||
| 02/18/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes Care | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA, BREZTRI | Food and Beverage | In-kind items and services | $78.11 | General |
| Category: Respiratory | ||||||
| 02/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardio-renal | ||||||
| 11/16/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 333 | 428 | $139,236 | $28,653 |
| 2022 | 10 | 420 | 542 | $165,749 | $32,657 |
| 2021 | 10 | 361 | 454 | $105,148 | $23,137 |
| 2020 | 9 | 381 | 499 | $132,477 | $22,073 |
Total Patients
1,495
Total Services
1,923
Medicare Billing
$106,519
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 130 | 192 | $83,220 | $14,701 | 17.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 61 | 61 | $28,670 | $7,538 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 77 | $22,484 | $4,315 | 19.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $1,365 | $985.53 | 72.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 23 | 23 | $2,047 | $696.90 | 34.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 17 | $782.00 | $161.84 | 20.7% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 12 | 13 | $156.00 | $152.88 | 98.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 30 | 32 | $512.00 | $100.92 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 233 | $100,820 | $17,971 | 17.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 109 | $31,828 | $6,327 | 19.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $14,570 | $3,937 | 27.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 23 | 23 | $2,415 | $1,616 | 66.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $8,906 | $1,204 | 13.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $2,047 | $672.98 | 32.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 13 | 15 | $2,775 | $459.14 | 16.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 32 | $1,480 | $307.07 | 20.7% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 45 | 48 | $768.00 | $131.34 | 17.1% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 14 | $140.00 | $31.01 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 140 | $58,865 | $11,576 | 19.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 86 | $25,112 | $4,610 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 19 | 19 | $8,930 | $2,450 | 27.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 18 | 18 | $1,890 | $1,166 | 61.7% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 20 | 20 | $1,800 | $798.00 | 44.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 20 | 20 | $1,800 | $796.79 | 44.3% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 17 | 18 | $1,620 | $716.99 | 44.3% |
About Dr. Terry Roach, DO
Dr. Terry Roach, DO is a Family Medicine healthcare provider based in Hurst, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831162585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Terry Roach, DO has received a total of $16,110 in payments from pharmaceutical and medical device companies, with $481.12 received in 2024. These payments were reported across 869 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($12,653).
As a Medicare-enrolled provider, Roach has provided services to 1,495 Medicare beneficiaries, totaling 1,923 services with total Medicare billing of $106,519. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hurst, TX
- Active Since 02/10/2006
- Last Updated 05/23/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1831162585
Products in Payments
- UBRELVY (Drug) $3,777
- FARXIGA (Drug) $945.94
- JARDIANCE (Drug) $924.77
- Vascepa (Drug) $595.70
- Ozempic (Drug) $537.69
- BEVESPI AEROSPHERE (Drug) $478.51
- CHANTIX (Drug) $337.67
- TRELEGY ELLIPTA (Drug) $294.08
- BREZTRI (Drug) $262.06
- TRULICITY (Drug) $229.45
- SYMBICORT (Drug) $227.42
- EMGALITY (Drug) $226.50
- JANUVIA (Drug) $224.58
- NORTHERA (Drug) $222.88
- QULIPTA (Drug) $218.07
- ANORO (Drug) $203.01
- Victoza (Drug) $200.05
- INVOKANA (Drug) $193.36
- VYVANSE (Drug) $192.35
- ELIQUIS (Drug) $184.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hurst
Christy Baze, D.o, D.O
Family Medicine — Payments: $6,814
Family Medicine $6,814
Dr. Robert Strzinek, D.o, D.O
Family Medicine — Payments: $3,778
Family Medicine $3,778
Dr. Charmaine Lobo, Md, MD
Family Medicine — Payments: $368.53
Family Medicine $368.53
Dr. Kelly Isbell, D.o, D.O
Family Medicine — Payments: $292.12
Family Medicine $292.12
Dr. Derek Lang, Do, DO
Family Medicine — Payments: $206.56
Family Medicine $206.56
Dr. Aubrey Guthrie, M.d,, M.D,
Family Medicine — Payments: $100.39
Family Medicine $100.39